Clinical Research Directory
Browse clinical research sites, groups, and studies.
Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
Sponsor: ART Fertility Clinics LLC
Summary
This study examines if monitoring serum Follicle Stimulation Hormone (FSH) levels can predict oocyte yield and progesterone levels, considering factors like age, baseline FSH, Antral Mullerian Hormone (AMH), antral follicle count, body weight, kidney function, and urinary FSH. The aim is to find a minimum FSH level that ensures optimal ovarian response and enables tailored FSH dosages for better outcomes.
Official title: Assessment of the Role of Serum FSH Monitoring During Ovarian Stimulation and Identification of an Optimal Range for Expected Normal Responders
Key Details
Gender
FEMALE
Age Range
18 Years - 39 Years
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2024-12-16
Completion Date
2025-12-01
Last Updated
2025-02-24
Healthy Volunteers
Yes
Conditions
Interventions
Gonal-f (gonadotropin)
Women will be given 300 IU Gonal-F daily from cycle day 2 or 3. Gonal F will be injected at 8 pm daily. They will all receive cetrorelix acetate 250 mcg/day (Cetrotide) subcutaneously from stimulation day 5 onwards until and including the trigger day. Cetrotide will be administered at 08:00 am.
Locations (1)
ART Fertility Clinics
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates